NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIAID E-033-1996-1-GB-12 MODIFIED MYELIN BASIC PROTEIN MOLECULES GB EP 96913035.0 Abandoned
NIAID E-033-1996-1-FR-11 MODIFIED MYELIN BASIC PROTEIN MOLECULES FR EP 96913035.0 Abandoned
NIAID E-033-1996-1-DE-10 MODIFIED MYELIN BASIC PROTEIN MOLECULES DE EP 96913035.0 Abandoned
NIAID E-033-1996-1-EP-04 MODIFIED MYELIN BASIC PROTEIN MOLECULES EP National Stage 96913035.0 Abandoned
NHGRI E-005-1997-0-US-01 METHOD FOR SIMULTANEOUS DETECTION OF MULTIPLE FLUOROPHORES FOR IN SITU HYBRIDIZATION AND MULTICOLOR CHROMOSOME PAINTING AND BANDING US ORD 08/635,820 5817462 Expired PDF
NIAID E-033-1996-1-PCT-01 MODIFIED MYELIN PROTEIN MOLECULES PCT PCT COMB PCT/US1996/005611 Expired
NIAID E-033-1996-1-JP-05 MODIFIED MYELIN BASIC PROTEIN MOLECULES0 JP National Stage 1996-533344 Abandoned
NIAID E-033-1996-1-MX-07 MODIFIED MYELIN BASIC PROTEIN MOLECULES MX National Stage 9708418 Abandoned
NIAID E-033-1996-1-CA-03 MODIFIED MYELIN BASIC PROTEIN MOLECULES CA National Stage 2218858 Abandoned
NIAID E-033-1996-1-AU-02 MODIFIED MYELIN BASIC PROTEIN MOLECULES AU National Stage 55658/96 Abandoned
NCI E-087-1996-0-US-01 HETEROLOGOUS BOOSTING IMMUNIZATIONS FOR THE GENERATION OF CTL AND ANTITUMOR RESPONSES US 60/015,893 Abandoned
NIAID E-082-1996-0-US-01 SIMIAN-HUMAN HAV HAVING A CHIMERIC 2C PROTEIN CHIMERIC 2C PROTEIN US 60/015,642 Abandoned
NCI E-088-1996-0-US-01 POINT MUTATED RAS PEPTIDES FOR THE GENERATION OF CD8+ CYTOTOXIC T LYMPHOCYTES US ORD 08/635,344 Abandoned
NIA E-146-1993-0-US-02 METHOD OF TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT US FWC 08/633,185 5616608 Expired PDF
NCI E-061-1996-0-US-01 IN VITRO PROGNOSTIC TEST FOR PROGESSORS AND NON-PROGRESSORS AFTER HIV INFECTION US 60/015,492 Abandoned
NIMH E-012-1991-6-US-01 METHODS OF INDUCING IMMUNE TOLERANCE USING IMMUNOTOXINS US 60/015,459 Abandoned
NIMH E-012-1991-5-CA-05 METHODS OF INDUCING IMMUNE TOLERANCE USING IMMUNOTOXINS CA National Stage 2218166 Expired
NIMH E-012-1991-5-EP-07 Methods of Inducing Immune Tolerance Using Immunotoxins EP National Stage 96913790.0 Abandoned
NIMH E-110-1993-1-US-01 ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM US CIP 08/631,427 5811093 Abandoned PDF
NIMH E-012-1991-5-PCT-01 METHODS OF INDUCING IMMUNE TOLERANCE USING IMMUNOTOXINS PCT PCT COMB PCT/US1996/005087 Expired
NEI E-185-1992-5-US-01 NOVEL RECEPTOR FOR PIGMENT EPITHELIUM-DERIVED FACTOR US 60/015,304 Abandoned
NCI E-065-1996-0-US-01 ACRIDONE-DERIVED COMPOUNDS USEFUL AS ANTINEOPLASTIC AND ANTIRETROVIRAL AGENTS US 60/015,326 Abandoned
NIA E-172-1996-0-US-01 USE OF FREE (F) PSA PROPORTION OF TOTAL (T) PSA TO SCREEN FOR PROSTATE CANCER (CaP) US ORD 08/631,031 Abandoned
NIMH E-012-1991-5-AU-04 THYMIC TOLERANCE IN PRIMATES AU National Stage 56637/96 Abandoned
NCI E-196-1992-5-CA-04 POLYSACCHARIDE-BOUND NITRIC OXIDE-NUCLEOPHILE ADDUCTS CA National Stage 2216696 Abandoned
NCI E-182-1996-0-US-01 Phenylacetate and Derivatives Alone or in Combination with other Compounds Against Neoplastic Conditions and Other Disorders. US CON 08/633,833 5852056 Abandoned PDF
NCI E-196-1992-5-AU-03 POLYSACCHARIDE-BOUND NITRIC OXIDE-NUCLEOPHILE ADDUCTS AU National Stage 54483/96 Abandoned
NIDDK E-003-1995-0-PCT-02 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO-[a,d]CYCLOHEPTEN-5,10-IMINES BY OPTICAL RESOLUTION PCT PCT PCT/US1996/004906 Expired
NCI E-196-1992-5-PCT-02 POLYSACCHARIDE-BOUND NITRIC OXIDE-NUCLEOPHILE ADDUCTS PCT PCT PCT/US1996/004899 Expired
NCI E-196-1992-4-PCT-02 Use of Nitric Oxide-Releasing Agents to Treat Impotency PCT PCT PCT/US1996/004889 Abandoned
NCI E-196-1992-4-JP-06 Use of Nitric Oxide-Releasing Agents to Treat Impotency JP National Stage 1996-531124 Abandoned
NCI E-196-1992-5-JP-05 POLYSACCHARIDE-BOUND NITRIC OXIDE-NUCLEOPHILE ADDUCTS JP National Stage 1996-531128 Abandoned
NIDDK E-003-1995-0-JP-04 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO[A,D]CYCLOHEPTEN-5, 10-IMINES BY OPTICAL RESOLUTION JP National Stage 1996-531130 Abandoned
NCI E-196-1992-4-KR-10 Use of Nitric Oxide-Releasing Agents to Treat Impotency KR National Stage 10-1997-0707196 Abandoned
NCI E-196-1992-4-AT-03 Use of Nitric Oxide-Releasing Agents to Treat Impotency AT EP A-9024/96 Abandoned
NCI E-196-1992-5-EP-06 POLYSACCHARIDE-BOUND NITRIC OXIDE-NUCLEOPHILE ADDUCTS EP National Stage 96911671.4 Abandoned
NCI E-196-1992-4-EP-05 Use of Nitric Oxide-Releasing Agents to Treat Impotency EP National Stage 96911665.6 Abandoned
NIDDK E-003-1995-0-EP-03 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO[A,D]CYCLOHEPTEN-5, 10-IMINES BY OPTICAL RESOLUTION EP National Stage 96912655.6 Abandoned
NIDDK E-023-1996-0-US-01 METHOD OF TREATMENT ISCHEMIC, HYPOXIC, OR ANOXIC BRAIN DAMAGE US 60/014,760 Abandoned
NIDDK E-003-1995-0-AU-10 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO[A,D]CYCLOHEPTEN-5, 10-IMINES BY OPTICAL RESOLUTION AU National Stage 55394/96 Abandoned
NIDDK E-003-1995-0-KR-07 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO[A,D]CYCLOHEPTEN-5, 10-IMINES BY OPTICAL RESOLUTION KR National Stage 70715/97 Abandoned
NCI E-196-1992-4-NO-11 Use of Nitric Oxide-Releasing Agents to Treat Impotency NO National Stage P974680 Abandoned
NIDDK E-003-1995-0-MX-08 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO[A,D]CYCLOHEPTEN-5, 10-IMINES BY OPTICAL RESOLUTION MX National Stage 9778334 Abandoned
NCI E-196-1992-4-PL-12 Use of Nitric Oxide-Releasing Agents to Treat Impotency PL National Stage P322742 Abandoned
NCI E-196-1992-4-CA-04 Use of Nitric Oxide-Releasing Agents to Treat Impotency CA National Stage 2217863 Abandoned
NCI E-196-1992-4-CN-07 Use of Nitric Oxide-Releasing Agents to Treat Impotency CN National Stage 96194362.9 Abandoned
NCI E-196-1992-4-CZ-08 Use of Nitric Oxide-Releasing Agents to Treat Impotency CZ National Stage PV 3204-97 Abandoned
NCI E-020-1995-0-CZ-08 USE OF NITRIC OXIDE-RELEASING AGENTS FOR REDUCING METASTASIS RISK CZ National Stage 3204-97 Abandoned
NIDDK E-003-1995-0-HU-05 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO[A,D]CYCLOHEPTEN-5, 10-IMINES BY OPTICAL RESOLUTION HU National Stage unassign Abandoned
NIDDK E-003-1995-0-IL-06 PREPARATION OF CHIRAL 5-AMINOCARBONYL-5H-DIBENZO[A,D]CYCLOHEPTEN-5, 10-IMINES BY OPTICAL RESOLUTION IL National Stage unassign Abandoned